Reflect Scientific, Inc.
RSCF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.16 | 0.02 | -0.64 | 0.26 |
| FCF Yield | 0.00% | -1.83% | -1.77% | 8.18% |
| EV / EBITDA | 11.47 | -11.41 | 26.55 | 9.94 |
| Quality | ||||
| ROIC | 5.77% | -21.90% | 3.71% | 36.09% |
| Gross Margin | 29.71% | 55.22% | 59.72% | 68.59% |
| Cash Conversion Ratio | 0.23 | -1.03 | 0.89 | -0.04 |
| Growth | ||||
| Revenue 3-Year CAGR | -2.76% | -27.33% | -9.92% | 20.49% |
| Free Cash Flow Growth | 0.00% | -13.02% | -111.07% | 3,396.78% |
| Safety | ||||
| Net Debt / EBITDA | -3.38 | 2.55 | -9.05 | -1.54 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 1.83 | 0.50 | 1.03 | 1.42 |
| Cash Conversion Cycle | 246.45 | 727.24 | 352.69 | 253.01 |